Rare diseases
Investigational molecules
Locations
A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
BelgiumStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
BelgiumLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
BelgiumStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
BelgiumStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
BelgiumStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
BelgiumStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
BelgiumStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
BelgiumTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
BelgiumStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
BelgiumStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
BelgiumStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
